Kirkland & Ellis International LLP

With notable strength in IP, clients frequently turn to Kirkland & Ellis International LLP for high-profile, multijurisdictional patent litigation involving small molecules, complex biologic products, medical devices, and diagnostics. The firm also advises investors and life sciences companies in technology and IP transactions, such as licensing and commercialisation agreements. The ‘exceptionally knowledgeable’ team is jointly led by ’star litigator’ Nicola Dagg; Daniel Lim, who draws on his biochemistry background to advise on patent litigation and IP strategy; and Emma Flett, experienced in the full spectrum of IP-related work, particularly high-value M&A. Other key figures include litigator Jin Ooi, praised for ‘combin(ing) deep technical knowledge with strategic thinking’. Gabriella Bornstein is no longer at the firm.